Molecular imaging methods such as positron emission tomography (PET) are increasingly
involved in the development of new drugs. Using radioactive tracers as imaging probes, PET …

Positron emission tomography (PET) is an extensively used nuclear functional imaging
technique, especially for central nervous system (CNS) and oncological disorders. Currently …

Human in vivo molecular imaging with positron emission tomography (PET) enables a new
kind of 'precision pharmacology', able to address questions central to drug development …

Positron emission tomography (PET), as an in vivo pharmacological imaging tool in
experimental medicine, is playing an increasing role in drug development. There are two …

Positron Emission Tomography (PET) is a sophisticated nuclear imaging modality that
affords researchers the ability to conduct both functional and molecular imaging on …

As drug discovery and development in Neuroscience push beyond symptom management
to disease modification, neuroimaging becomes a key area of translational research that …

Molecular imaging is an emerging technology that allows the visualization of interactions
between molecular probes and biological targets. Molecules that either direct or are subject …

Positron emission tomography (PET) is a non-invasive technology of nuclear medicine that
has sensitivity for tracing low picomolar concentrations of radiolabeled molecules in the …

Positron emission tomography (PET) is increasingly used in drug discovery and
development for evaluation of CNS drug disposition and for studies of disease biomarkers to …

In this review, the value of functional imaging [positron emission tomography (PET)/single-
photon emission computed tomography (SPECT)] in drug development is considered …